IN2013MU03421A - - Google Patents

Info

Publication number
IN2013MU03421A
IN2013MU03421A IN3421MU2013A IN2013MU03421A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A IN 3421MU2013 A IN3421MU2013 A IN 3421MU2013A IN 2013MU03421 A IN2013MU03421 A IN 2013MU03421A
Authority
IN
India
Prior art keywords
pharmaceutically acceptable
acceptable derivative
sulbactam
cefepime
stereoisomer
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3421MU2013 priority Critical patent/IN2013MU03421A/en
Priority to US15/030,061 priority patent/US20160271118A1/en
Priority to PCT/IB2014/065708 priority patent/WO2015063714A1/en
Priority to EP14811971.2A priority patent/EP3062794B1/en
Publication of IN2013MU03421A publication Critical patent/IN2013MU03421A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3421MU2013 2013-10-30 2014-10-30 IN2013MU03421A (enrdf_load_stackoverflow)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN3421MU2013 IN2013MU03421A (enrdf_load_stackoverflow) 2013-10-30 2014-10-30
US15/030,061 US20160271118A1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents
PCT/IB2014/065708 WO2015063714A1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents
EP14811971.2A EP3062794B1 (en) 2013-10-30 2014-10-30 Pharmaceutical compositions comprising antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3421MU2013 IN2013MU03421A (enrdf_load_stackoverflow) 2013-10-30 2014-10-30

Publications (1)

Publication Number Publication Date
IN2013MU03421A true IN2013MU03421A (enrdf_load_stackoverflow) 2015-07-17

Family

ID=52023565

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3421MU2013 IN2013MU03421A (enrdf_load_stackoverflow) 2013-10-30 2014-10-30

Country Status (4)

Country Link
US (1) US20160271118A1 (enrdf_load_stackoverflow)
EP (1) EP3062794B1 (enrdf_load_stackoverflow)
IN (1) IN2013MU03421A (enrdf_load_stackoverflow)
WO (1) WO2015063714A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6643484B2 (ja) * 2015-12-11 2020-02-12 ウォックハート リミテッド ７−オキソ−６−（スルホオキシ）−１，６−ジアザビシクロ［３．２．１］オクタン−２−カルボキサミド含有化合物および細菌感染症の治療におけるそれらの使用
BR112019013527A2 (pt) * 2017-03-02 2020-01-07 Wockhardt Limited Derivados heterocíclicos como compostos antibacterianos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ616806A (en) * 2011-07-26 2015-03-27 Wockhardt Ltd Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
BR112015003592B1 (pt) * 2012-08-25 2020-04-14 Wockhardt Ltd derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas

Also Published As

Publication number Publication date
EP3062794A1 (en) 2016-09-07
WO2015063714A1 (en) 2015-05-07
US20160271118A1 (en) 2016-09-22
EP3062794B1 (en) 2018-09-26

Similar Documents

Publication Publication Date Title
PH12018500591B1 (en) Heterocyclic compounds and uses thereof
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2018001990A (es) Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac.
JO3452B1 (ar) بنزاميدات أمينو اريل مغاير كمثبطات كيناز
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2018014813A (es) Composiciones antibacterianas.
MX2015015562A (es) Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2.
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
MX363530B (es) Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo.
MX2017003138A (es) Compuestos de azetidiniloxifenilpirrolidina.
IN2014MU00859A (enrdf_load_stackoverflow)
IN2013MU03308A (enrdf_load_stackoverflow)
IN2013MU03421A (enrdf_load_stackoverflow)
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
IN2013MU03704A (enrdf_load_stackoverflow)
IN2013MU03422A (enrdf_load_stackoverflow)
IN2013MU03309A (enrdf_load_stackoverflow)
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
IN2014MU01194A (enrdf_load_stackoverflow)
IN2013MU03565A (enrdf_load_stackoverflow)
MX2017010992A (es) Composiciones farmaceuticas estables que comprenden agente antibacteriano.